Verition Fund Management’s HilleVax HLVX Stock Holding History

Verition Fund Management’s Portfolio HLVX Stock Details HLVX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-37,625	Closed	-$74.9K	–	3867
2025 Q2	$74.9K	Sell	37,625 -79,130	-68%	-$145K	﹤0.01%	3506
2025 Q1	$169K	Sell	116,755 -51,080	-30%	-$94.4K	﹤0.01%	3083
2024 Q4	$347K	Sell	167,835 -20,200	-11%	-$37.9K	﹤0.01%	2690
2024 Q3	$331K	Buy	+188,035	New	+$482K	﹤0.01%	2581

Verition Fund Management's HLVX Position: Q3 2025 in Review

Verition Fund Management sold out of HilleVax (HLVX) in Q3 2025, closing a stake of 37,625 shares — an estimated $74.9K sold.

Verition Fund Management first reported a position in HLVX in Q3 2024 and held it in 4 quarters. The position peaked at $347K in Q4 2024. 1 fund tracked by Wall St. Rank holds HLVX as of Q3 2025.

Verition Fund Management reported no remaining HilleVax position as of Q3 2025 after selling out during the quarter.
Verition Fund Management sold 37,625 HilleVax shares in Q3 2025, an estimated $74.9K.
Verition Fund Management first reported a position in HilleVax in Q3 2024 and held it in 4 quarters.
Verition Fund Management's HilleVax position peaked at $347K in Q4 2024.
1 fund tracked by Wall St. Rank held HilleVax as of Q3 2025.

Based on Verition Fund Management's 13F filing for Q3 2025, filed 14 Nov 2025.